More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.

With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.

In addition to giving patients standard verbal breath-holding instructions, the segment offers them an idea of what to expect ...

The FLASH protocol, associated with less radiation than a CAC scan, should be used more often in this cohort, a researcher ...

Recommendations around dosing, duration, and patient-specific options are woven into the fabric of the scientific statement.

Results from the DAPT-MVD trial, while not necessarily generalizable, do open the door to a new tactic in select cases.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

The meeting offers something for all: from the practicalities of running a cardiac CT program to the effect of AI on the ...

The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance.

The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.

The findings should lead to changes in practice, David Cohen says, but as seen in the setting of PCI, “old habits die hard.” ...

The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...